Showing results (1951-1960 of 2,089) with videos related to

Sort By:
Pageof 209
Plos One|April 19, 2018
A case study of polypharmacy management in nine European countries: Implications for change management and implementationJennifer McIntosh, Albert Alonso, Katie MacLure, et al.
European Journal of Clinical Nutrition|March 24, 2011
Use of a common food frequency questionnaire (FFQ) to assess dietary patterns and their relation to allergy and asthma in Europe: pilot study of the GA2LEN FFQV Garcia-Larsen, M Luczynska, M L Kowalski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experienceP Berlanga, C Pasqualini, U Pötschger, et al.
European Heart Journal. Cardiovascular Imaging|May 20, 2024
Longitudinal comparison of dyssynchrony correction and 'strain' improvement by conduction system pacing: LEVEL-AT trial secondary findingsMargarida Pujol-López, Rafael Jiménez-Arjona, Cora Garcia-Ribas, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.
Journal of Clinical Medicine|June 10, 2023
Multimodal Prehabilitation in Heart Transplant Recipients Improves Short-Term Post-Transplant Outcomes without Increasing CostsManuel López-Baamonde, María José Arguis, Ricard Navarro-Ripoll, et al.
Journal of Cardiac Failure|November 14, 2021
Cardiac Transplantation in Danon DiseaseKimberly N Hong, Carol Battikha, Sonya John, et al.
Journal of Oncology|February 28, 2022
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter StudyCharles Vauchier, Edouard Auclin, Philippe Barthélémy, et al.
BMC Cancer|August 9, 2023
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC studyFrançois Gernier, Jean-Michel Grellard, Charlotte Dupont, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2023
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of UrologyStéphanie Delaval, Pierre-Luc Dequirez, Claire Hentzen, et al.
Pageof 209